Recently, it is gradually recognized that some B-cell subpopulations including regulatory B cells can impair CD4+ T cell activation or produce cytokines promote tumor progression [33–35], Leading to dramatically suppress antibody and inhibit antitumor effector T cells [34,36]. The gene discussed is CD4; the disease is neoplasm.